Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
Nov 23, 2010 goldstein joseph l Director Option Execute 10,000 15.01 - 18.80
Dec 16, 2010 goldstein joseph l Director Option Execute 10,000 15.01
Oct 14, 2011 goldstein joseph l Director Automatic Sell 10,000 65.00
Oct 14, 2011 goldstein joseph l Director Option Execute 10,000 23.84
Sep 20, 2011 goldstein joseph l Director Acquisition (Non Open Market) 10,000 n/a
Jan 19, 2012 goldstein joseph l Director Automatic Sell 10,000 80.00
Mar 15, 2012 goldstein joseph l Director Automatic Sell 10,000 110.77 - 115.00
Mar 15, 2012 goldstein joseph l Director Option Execute 10,000 18.61
Mar 25, 2014 goldstein joseph l Director Acquisition (Non Open Market) 10,000 n/a
Sep 1, 2011 larosa joseph j Officer Acquisition (Non Open Market) 10,000 n/a
Jan 7, 2011 roberts william Officer Option Execute 10,000 9.49
Jun 14, 2010 ryan arthur f Director Buy 10,000 26.98
Nov 1, 2012 ryan arthur f Director Sell 10,000 145.57
Aug 10, 2012 ryan arthur f Director Sell 10,000 136.15
Feb 26, 2013 shooter eric m Director Acquisition (Non Open Market) 10,000 n/a
Feb 26, 2013 shooter eric m Director Sell 10,000 160.00
Oct 2, 2007 shooter eric m Director Sell 10,000 18.30 - 18.37
Oct 2, 2007 shooter eric m Director Option Execute 10,000 7.66
May 6, 2013 shooter eric m Director Acquisition (Non Open Market) 10,000 n/a
May 6, 2013 shooter eric m Director Sell 10,000 258.78 - 264.18
Showing 401-420 of 821 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)